ArticleInfection and drug resistance2026
Brucellosis with Multisystem Involvement: A Case Report Focusing on Neurological Manifestations and Drug-Induced Dermatitis-Diagnostic and Therapeutic Dilemmas.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brucellosis is a widespread zoonotic infection with a broad spectrum of clinical manifestations, often leading to delayed diagnosis and multisystem complications. While typical symptoms include fever, arthralgia, and hepatosplenomegaly, neurological involvement and severe drug reactions are uncommon and pose diagnostic and therapeutic challenges. A 54-year-old male farmer from an endemic area in Inner Mongolia presented with a six-month history of recurrent polyarthralgia, followed by progressive neurological deficits including muscle weakness, sensory impairment, and bilateral adductor pollicis atrophy. Despite confirmed brucellosis serology and standard antibiotic therapy (rifampicin and doxycycline), his symptoms persisted. He later developed generalized drug-induced dermatitis after taking Zhenbao Pill, which resolved only partially upon discontinuation. Lumbar magnetic resonance imaging (MRI) showed multilevel intervertebral disc protrusion, and brain MRI revealed cerebral white matter hyperintensities and small lacunar infarcts. Given the patient's epidemiological exposure history, progressive clinical symptoms and abnormal imaging findings, suspected neurobrucellosis and possible brucellosis-associated neuropathy were considered clinically, with definitive diagnosis pending further cerebrospinal fluid examination, nerve conduction studies and electromyography. This case highlights the clinical possibility of progressive neurological impairment and potential herbal medicine-related cutaneous adverse reactions in patients with brucellosis. The novelty of this case lies in the co-occurrence of suspected brucellosis-related neurological involvement and drug/herbal-induced dermatitis. This study reminds clinicians to enhance vigilance against atypical and complex manifestations of brucellosis, conduct comprehensive differential diagnosis, and adopt a multidisciplinary collaborative strategy for the standardized management of such intractable cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.